TCT-492 External Validation of the SYNTAX Score II 2020 in the CREDO-Kyoto PCI/CABG Registry

Hironori Hara; Hiroki Shiomi; David van Klaveren; David M. Kent; Ewout W. Steyerberg; Scot Garg; Yoshinobu Onuma; Takeshi Kimura; Patrick W. Serruys

doi:10.1016/j.jacc.2021.09.1345

Related publications

Article2021

External Validation of the SYNTAX Score II 2020

Hironori Hara, Hiroki Shiomi, David van Klaveren, David M. Kent, Ewout W. Steyerberg, Scot Garg, Yoshinobu Onuma, Takeshi Kimura, Patrick W. Serruys

Journal of the American College of Cardiology

Letter2013

Observations from the CREDO-Kyoto three-vessel disease registry: can one adjust for the unadjustable?

Vasim Farooq, Patrick W. Serruys

EuroIntervention

Article2017

TCT-221 Treatment Recommendations Based on SYNTAX Score II and Observed 3-year Mortality in the EXCEL Trial

Patrick W. Serruys, Carlos Collet, Yoshinobu Onuma, Marie‐Angèle Morel, Ovidiu Dressler, Yiran Zhang, Martin B. Leon, Marie‐Claude Morice, Philippe Généreux, David E. Kandzari, A. Pieter Kappetein, Joseph F. Sabik, Gregg W. Stone

Journal of the American College of Cardiology

Article2010

THE IMPACT OF RENAL INSUFFICIENCY ON 2-YEAR OUTCOMES FOLLOWING PCI OR CABG IN THE SYNTAX TRIAL

David R. Holmes, Friedrich W. Mohr, Patrick W. Serruys, Michael J. Mack, Paul Vermeersch, P Van Cauwelaert, Kari Virtanen, Ari Harjula, Katrin Leadley, Keith D. Dawkins

Journal of the American College of Cardiology

Article2018

TCT-675 Site versus Core Laboratory SYNTAX score variability

Carlos Collet, Yosuke Miyazaki, Daniele Andreini, Antonio L. Bartorelli, Jeroen Sonck, Johan De Mey, Bert Vandeloo, Taku Asano, Yuki Katagiri, Ulf Teichgräber, Torsten Doenst, Marie‐Angèle Morel, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

TCT-492 External Validation of the SYNTAX Score II 2020 in the CREDO-Kyoto PCI/CABG Registry

Abstract

Discussion(0)

Related publications

External Validation of the SYNTAX Score II 2020

Observations from the CREDO-Kyoto three-vessel disease registry: can one adjust for the unadjustable?

TCT-221 Treatment Recommendations Based on SYNTAX Score II and Observed 3-year Mortality in the EXCEL Trial

THE IMPACT OF RENAL INSUFFICIENCY ON 2-YEAR OUTCOMES FOLLOWING PCI OR CABG IN THE SYNTAX TRIAL

TCT-675 Site versus Core Laboratory SYNTAX score variability